Clinical Trials Logo

Clinical Trial Summary

Patients hospitalized in intensive care between January 2014 and December 2023 for ketoacidosis complicated by organ failure in participating departments.


Clinical Trial Description

Analysis of patients with International Statistical Classification of Diseases and Related Health Problems coding compatible with inclusion - Selection of patients eligible for inclusion based on review of medical records (verification of inclusion and non-inclusion criteria) - Telephone contact and sending of the information letter on participation in the study and research of the patient's non-opposition to his participation and the processing of his data. - Collection of retrospective data - Phone call to collect prospective data ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05488262
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase
Start date February 2, 2024
Completion date June 14, 2024

See also
  Status Clinical Trial Phase
Completed NCT02077348 - Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection. N/A
Completed NCT02157155 - A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis N/A
Completed NCT05442918 - Expected Normal Ketone Values After Very Low and Bariatric Surgery
Terminated NCT01631929 - Two Bag System for Hydration in Diabetes N/A